FITC anti-human CD45RO 304242 from BioLegend

Product Specs
ItemFITC anti-human CD45RO
CompanyBioLegend
Price $141.00Supplier Page View Company Product Page
Catalog Number304242
Quantity100 µg
ApplicationsFC - Quality tested
Concentrationµg size: 0.5 mg/mLtest size: lot-specific
Conjugate/TagFITC
Formatµg size: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
test size: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
ReactivityHuman
IsotypeMouse IgG2a, kappa
CloneUCHL1
HostMouse
Antibody TypePrimary
ImmunogenIL-2 dependent T cell line, CA1
NCBI Full Gene Nameprotein tyrosine phosphatase receptor type C
NCBI Gene AliasesB220, CD45, CD45R, GP180, IMD105, L-CA, LCA, LY5, T200
ClonalityMonoclonal
TargetCD45RO

Add to Compare List

BioLegend

8999 BioLegend Way

San Diego, California 92121

United States

Phone: 1-877-246-5343 Toll-Free, USA & Canada
1-858-768-5800 International
Fax: 1-877-455-9587

Company Profile

Website: biolegend.com

(1) Intrathecal CRISPR-edited allogeneic IL-13Rα2 CAR T Cells for recurrent high-grade Glioma: preclinical characterization and phase I trialNature CommunicationsJanuary 6, 2026Xuetao Li, Xiaoyun Shang, Jiangang Liu, Yang Zhang, Xian Jia, Huabing Li, Yihan Wang, Jianen Gao, Xu Ma, Xuewen Zhang, et al.DREG-56, Thermo Fisher Scientific, Cat# 46-0629-42), and CD45RO-FITC (clone UCHL1, BioLegend, Cat# 304242). Detailed information of all antibodies, including clones, manufacturers and catalog numbers, and dilutions

(2) Superinfection promotes replication and diversification of defective HIV-1 proviruses in people with non-suppressible viraemiaNature MicrobiologyOctober 3, 2025Vivek Hariharan, Jennifer A. White, Filippo Dragoni, Emily J. Fray, Nicholas Pathoulas, Milica Moskovljevic, Hao Zhang, Anushka Singhal, Jun Lai, Subul A. Beg, et al.(Biolegend, 301016; clone RPA-T8), CD4-BV421 (Biolegend, 317434; clone OKT4), CD45RO-FITC (Biolegend, 304242; clone UCHL1) and Live/Dead Fixable Near-IR viability dye (ThermoFisher, L34975). Cells were then fixed

(3) Vaccination with inactivated SARS-CoV-2 vaccine TURKOVAC induces durable humoral and cellular immune responses up to 8 monthsFrontiers in MedicineApril 28, 2025Seçil Yılmaz, Ahmet Eken, Zafer Sezer, Burcu Şen Bağcı, Serife Erdem, Medine Doğan Sarıkaya, Busra Kaplan, Ahmet Inal, Adnan Bayram, Gamze Kalın Unuvar, et al.CD3-APC, CD4-PE, CXCR5-PB (Biolegend, #356918), OX40-BV510, CD69-Alexa 700, CD45RO-FITC (Biolegend, #304242), CCR6-PerCP/Cy5.5 (Biolegend, #353406), CXCR3-PE/Dazzle™ 594 (Biolegend, #353736), and CD40L-PE (Biolegend,

(4) Rapidly Manufactured CAR-T with Conserved Cell Stemness and Distinctive Cytokine-Secreting Profile Shows Improved Anti-Tumor EfficacyVaccines (Basel)November 28, 2024Shih-Ting Tsao, Mingyuan Gu, Qinghui Xiong, Yingzhi Deng, Tian Deng, Chengbing Fu, Zihao Zhao, Haoyu Zhang, Cuicui Liu, Xiong Zhong, et al.PE Streptavidin (1:200, BioSwan, 700032; Shanghai, China); FITC anti-human CD45RO (1:50, BioLegend, 304242; San Diego, CA, USA); and PE anti-human CD197 (CCR7) Antibody (1:100, BioLegend, 353204; San Diego,

(5) Human CD4(+) memory phenotype T cells use mitochondrial metabolism to generate sensitive IFN-γ responsesiScienceMay 17, 2024Bharadwaj NS, Zumwalde NA, Kapur A, Patankar M, Gumperz JE.HLA-A,B,C (W6/32)",Biolegend,Cat# 311438; RRID:AB_2566306 anti-human CD45RO (UCHL1),Biolegend,Cat# 304242; RRID:AB_314420 anti-human CD45RA (HI100),Biolegend,Cat# 304122; RRID:AB_893357 anti-human CD31 (WM59),Biolegend,Cat#

(6) MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humansnpj VaccinesJanuary 26, 2024Leonie Mayer, Leonie M. Weskamm, Anahita Fathi, Maya Kono, Jasmin Heidepriem, Verena Krähling, Sibylle C. Mellinghoff, My Linh Ly, Monika Friedrich, Svenja Hardtke, et al.anti-CD8-APC-Cy7 (1:100; #344714; BioLegend), anti-CCR7-AF647 (1:50; #353218; BioLegend), anti-CD45RO-FITC (1:33; #304242; BioLegend), and Zombie Aqua™ Fixable Viability Kit (1:500; #423101; BioLegend) in FACS buffer [PBS

(7) Peripheral T cell profiling reveals downregulated exhaustion marker and increased diversity in lymphedema post-lymphatic venous anastomosisiScienceJune 16, 2023Imai H, Kawase T, Yoshida S, Mese T, Roh S, Fujita A, Uchiki T, Sasaki A, Nagamatsu S, Takazawa A, et al.G043H7),Biolegend,Cat#353232; RRID: AB_2563866 FITC anti-human CD45RO (clone: UCHL1),Biolegend,Cat#304242; RRID: AB_2564159 APC anti-human CD95 (clone: DX2),Biolegend,Cat#305612; RRID: AB_314550 BV421 anti-human

(8) T-cell responses to SARS-CoV-2 Omicron spike epitopes with mutations after the third booster dose of an inactivated vaccineJournal of medical virologyAugust 1, 2022Li Y, Wang X, Jin J, Ma Z, Liu Y, Zhang X, Su B.605™ anti‐human CD69, 310938; BioLegend; APC/Cy7 anti‐human CD45RA, 304128, FITC anti‐human CD45RO, 304242). In brief, cells were resuspended in PBS with 2% FBS at a density of 1 × 107 cells/ml. The cells were

(9) Hydroxychloroquine inhibits the mitochondrial antioxidant system in activated T cellsiScienceDecember 17, 2021Kim ML, Hardy MY, Edgington-Mitchell LE, Ramarathinam SH, Chung SZ, Russell AK, Currie I, Sleebs BE, Purcell AW, Tye-Din JA, et al.

(10) The cell-surface 5'-nucleotidase CD73 defines a functional T memory cell subset that declines with ageCell reportsNovember 9, 2021Fang F, Cao W, Zhu W, Lam N, Li L, Gaddam S, Wang Y, Kim C, Lambert S, Zhang H, et al.

(11) Redefining COVID-19 Severity and Prognosis: The Role of Clinical and ImmunobiotypesFrontiers in immunologyJanuary 1, 2021Torres-Ruiz J, Pérez-Fragoso A, Maravillas-Montero JL, Llorente L, Mejía-Domínguez NR, Páez-Franco JC, Romero-Ramírez S, Sosa-Hernández VA, Cervantes-Díaz R, Absalón-Aguilar A, et al.

(12) CD8⁺ T cell subpopulations and pro-inflammatory cytokines in neuromyelitis optica spectrum disorderAnnals of clinical and translational neurologyJanuary 1, 2021Shi Z, Qiu Y, Zhao Z, Wen D, Chen H, Du Q, Zhang Y, Wang J, Yan C, Yang M, et al.

(13) Analysis of KSHV B lymphocyte lineage tropism in human tonsil reveals efficient infection of CD138+ plasma cellsPLoS pathogensOctober 1, 2020Aalam F, Nabiee R, Castano JR, Totonchy J.

(14) Early T Cell Activation Metrics Predict Graft-versus-Host Disease in a Humanized Mouse Model of Hematopoietic Stem Cell TransplantationJournal of immunology (Baltimore, Md. : 1950)July 1, 2020Hess NJ, Hudson AW, Hematti P, Gumperz JE.

(15) Increased frequency of CD4(+) PD-1(+) HLA-DR(+) T cells is associated with disease progression in CLLBritish journal of haematologyMarch 1, 2020Elston L, Fegan C, Hills R, Hashimdeen SS, Walsby E, Henley P, Pepper C, Man S.

(16) Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancerJournal of translational medicineNovember 26, 2018Pu X, Zhang R, Wang L, Chen Y, Xu Y, Pataer A, Meraz IM, Zhang X, Wu S, Wu L, et al.

(17) Distinct Transcriptional and Alternative Splicing Signatures of Decidual CD4⁺ T Cells in Early Human PregnancyFrontiers in immunologyJanuary 1, 2017Zeng W, Liu Z, Liu X, Zhang S, Khanniche A, Zheng Y, Ma X, Yu T, Tian F, Liu XR, et al.

(18) Bcl-xL regulates CD1d-mediated antigen presentation to NKT cells by altering CD1d trafficking through the endocytic pathwayJournal of immunology (Baltimore, Md. : 1950)September 1, 2014Subrahmanyam PB, Carey GB, Webb TJ.

(19) A novel self-assembled nanoparticle vaccine with HIV-1 Tat₄₉₋₅₇/HPV16 E7₄₉₋₅₇ fusion peptide and GM-CSF DNA elicits potent and prolonged CD8⁺ T cell-dependent anti-tumor immunity in miceVaccineFebruary 1, 2012Tang J, Yin R, Tian Y, Huang Z, Shi J, Fu X, Wang L, Wu Y, Hao F, Ni B.

(20) In vivo expansion of naive and activated CD4+CD25+FOXP3+ regulatory T cell populations in interleukin-2-treated HIV patientsProceedings of the National Academy of Sciences of the United States of AmericaJune 8, 2010Weiss L, Letimier FA, Carriere M, Maiella S, Donkova-Petrini V, Targat B, Benecke A, Rogge L, Levy Y.

Write a Review

(1)

12/10/2018FITC Anti-Human CD45RO Antibody Gemma FouldsThis antibody has been used to optimise flow cytometry-based immunophenotyping of whole blood samples. The results have not yet been published. Multi-colour antibody panels were designed to identify a... Read Review

FITC anti-human CD45RO from BioLegend

Description

BioLegend

Citations (25)

Reviews

FITC anti-human CD45RO from BioLegend

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map